Physician profile
Jonathan E Vogel
NPI 1104007533
$26,345.93
in general payments reported to CMS, 2019-2025
41 companies · $1,714 in 2025
The $1,714 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $8,980 · 2021: $7,727 · 2022: $4,569 · 2023: $1,245 · 2024: $2,111 · 2025: $1,714.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,031 · Education: $39.35.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,030.98 |
| Education | $39.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $11,600.35 | 2021-2025 | Qulipta, Ubrelvy, Botox |
| Allergan, INC. | $9,778.17 | 2020-2022 | |
| Novartis Pharmaceuticals Corporation | $740.82 | 2020-2025 | |
| Biogen, INC. | $706.40 | 2021-2025 | Vumerity, Tysabri |
| Celgene Corporation | $348.57 | 2021-2025 | Zeposia |
| Catalyst Pharmaceuticals, INC. | $288.07 | 2021-2025 | Fycompa |
| Pfizer INC. | $260.23 | 2023-2025 | |
| Lundbeck LLC | $258.73 | 2020-2025 | Vyepti |
| Ucb, INC. | $256.60 | 2022-2025 | Rystiggo, Briviact |
| Genentech USA, INC. | $246.17 | 2022-2025 | Ocrevus, Enspryng, Ocrevus Zunovo |
| Emd Serono, INC. | $181.63 | 2024-2025 | |
| Amgen INC. | $125.61 | 2021-2024 | Aimovig |
| Teva Pharmaceuticals USA, INC. | $114.88 | 2023-2025 | Austedo Xr, Ajovy |
| Tg Therapeutics, INC. | $111.75 | 2024-2025 | |
| Upsher-Smith Laboratories LLC | $110.07 | 2021-2023 |
Show all 41 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Vogel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.